Spectrum Pharmatech Consultants Private Limited, a active private limited company, was established on 09 September 2002 in Thane, Maharashtra, India. Engaging in procurement & construction (epc) within the professional, scientific and technical sector, it holds CIN: U74999MH2002PTC137116. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Employing 126 professional, Its leadership includes Aniruddha Jitendra Parmar (Director), Padma Swaminathan (Director), Swaminathan Ramchandran Subramaniam (Director). It holds ₹21.44 Cr open charges and ₹55.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302-B Dosti Pinnacle, Plot No E-7 , Road No.22 Wagle Industrial Estate, Thane West, Thane, Maharashtra, 400604.
U74999MH2002PTC137116
137116
09 September 2002
₹1.00 Cr
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Spectrum Pharmatech Consultants Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aniruddha Jitendra Parmar | Director | 19 Sep 2002 | Current |
| Padma Swaminathan | Director | 19 Sep 2002 | Current |
| Swaminathan Ramchandran Subramaniam | Director | 19 Sep 2002 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spectrum Pharmatech Consultants Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.1% decrease. The company also saw a substantial improvement in profitability, with a 41.54% increase in profit. The company's net worth moved up by a moderate rise of 4.86%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Spectrum Pharmatech Consultants had a promoter holding of 92.32% and a public holding of 7.68%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹214,370,000.00
₹557,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2025 | Others | ₹2.31 Cr | Open |
| 14 Feb 2025 | Others | ₹3.63 Cr | Open |
| 14 Feb 2025 | Others | ₹10.00 Cr | Open |
| 20 Mar 2024 | Hdfc Bank Limited | ₹3.00 Cr | Open |
| 07 Feb 2023 | Others | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Spectrum Pharmatech Consultants has a workforce of 126 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spectrum Pharmatech Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Pharmatech Consultants's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others amounted to Rs. 2.31 Cr with Charge ID 101171336 was registered on 13 Oct 2025. was completed.
Progress on A charge with Others of Rs. 3.63 Cr registered on 14 Feb 2025 with Charge ID 101070930 was modified on 06 Jun 2025. was documented.
The activity A charge with Others of Rs. 10.00 Cr registered on 14 Feb 2025 with Charge ID 101070922 was modified on 06 Jun 2025. was completed.
A charge with Hdfc Bank Limited of Rs. 3.00 Cr registered on 20 Mar 2024 with Charge ID 100911887 was modified on 24 Apr 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 3.63 Cr with Charge ID 101070930 was registered on 14 Feb 2025. was documented.
Progress on A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101070922 was registered on 14 Feb 2025. was documented.
The CIN of Spectrum Pharmatech Consultants Private Limited is U74999MH2002PTC137116.
Spectrum Pharmatech Consultants Private Limited is headquartered at 302-B Dosti Pinnacle, Plot No E-7 , Road No.22 Wagle Industrial Estate, Thane West, Thane, Maharashtra, 400604.
Spectrum Pharmatech Consultants Private Limited was incorporated on 09 September 2002.
The current directors of Spectrum Pharmatech Consultants Private Limited are
The primary industry of Spectrum Pharmatech Consultants Private Limited is Professional, Scientific And Technical.
Spectrum Pharmatech Consultants Private Limited is unlisted.
The authorized capital of Spectrum Pharmatech Consultants Private Limited is ₹1.00 Cr, and the paid-up capital is ₹5.00 M.
The compliance status of Spectrum Pharmatech Consultants Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX